| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030728 |
| Receipt No. | R000035086 |
| Scientific Title | A pain-killing effect of Platelet Rich Fibrin after extraction of an impacted wisdom tooth |
| Date of disclosure of the study information | 2018/01/09 |
| Last modified on | 2020/07/13 (Ver. 2) |
| Basic information | ||
| Public title | A pain-killing effect of Platelet Rich Fibrin after extraction of an impacted wisdom tooth | |
| Acronym | A pain-killing effect of Platelet Rich Fibrin after extraction of an impacted wisdom tooth | |
| Scientific Title | A pain-killing effect of Platelet Rich Fibrin after extraction of an impacted wisdom tooth | |
| Scientific Title:Acronym | A pain-killing effect of Platelet Rich Fibrin after extraction of an impacted wisdom tooth | |
| Region |
|
|
| Condition | ||
| Condition | an impacted wisdom tooth | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Examine a pain-killing effect of PRF after extraction of an impacted tooth |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The decline rate of visual analog scale at seven days after extraction |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Insert PRF to extraction socket immediate after tooth extraction | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. The person who receives a consent for the documentary participation in this study. | |||
| Key exclusion criteria | 1. Patients with any blood disease
2. When the VAS, the recording of the diary is impossible 3. Patients who regularly use analgesics 4. Patients who regularly use psychotropics 5. Pregnant women, lactating women, patients with the possibility of pregnancy 6. Patients with penicillin drug allergy 7. Patients with aspirin asthma 8. Infectious mononucleosis patients 9. Patinets with a history of peptic ulcer 10. The person whom a doctor disqualifyied for this study |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya City University Graduate School of Medical Sciences | ||||||
| Division name | Department of Oral and Maxillofacial Surgery | ||||||
| Zip code | |||||||
| Address | 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya | ||||||
| TEL | (052)858-7302 | ||||||
| nao70231011@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya City University Graduate School of Medical Sciences | ||||||
| Division name | Department of Oral and Maxillofacial Surgery | ||||||
| Zip code | |||||||
| Address | 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya | ||||||
| TEL | (052)858-7302 | ||||||
| Homepage URL | |||||||
| Miya0331@me.com | |||||||
| Sponsor | |
| Institute | Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035086 |